MX2011009679A - Dispositivo de suministro de farmaco zootecnico. - Google Patents

Dispositivo de suministro de farmaco zootecnico.

Info

Publication number
MX2011009679A
MX2011009679A MX2011009679A MX2011009679A MX2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A MX 2011009679 A MX2011009679 A MX 2011009679A
Authority
MX
Mexico
Prior art keywords
drug delivery
zoo
delivery device
technical
active substances
Prior art date
Application number
MX2011009679A
Other languages
English (en)
Inventor
Raymond Zeeman
Marc-Antoine Driancourt
Wouter De Graff
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2011009679A publication Critical patent/MX2011009679A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a un sistema (dispositivo) de suministro de fármaco zootécnico veterinario para la liberación simultánea de dos o más sustancias activas, en donde el sistema libera las sustancias activas en una relación sustancialmente constante durante un periodo de tiempo prolongado. El sistema de suministro de fármaco puede estar en diferentes formas, tal como por ejemplo, un implante, o un dispositivo intravaginal tal como una bobina helicoidal, resorte o anillo.
MX2011009679A 2009-03-17 2010-03-15 Dispositivo de suministro de farmaco zootecnico. MX2011009679A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16093909P 2009-03-17 2009-03-17
EP09155385 2009-03-17
PCT/EP2010/053240 WO2010105995A2 (en) 2009-03-17 2010-03-15 Zoo-technical drug delivery device

Publications (1)

Publication Number Publication Date
MX2011009679A true MX2011009679A (es) 2011-09-30

Family

ID=42115744

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009679A MX2011009679A (es) 2009-03-17 2010-03-15 Dispositivo de suministro de farmaco zootecnico.

Country Status (10)

Country Link
US (2) US9198857B2 (es)
EP (1) EP2408423A2 (es)
AR (1) AR076123A1 (es)
AU (1) AU2010224957B2 (es)
BR (1) BRPI1009586A2 (es)
CA (1) CA2755828A1 (es)
MX (1) MX2011009679A (es)
UY (1) UY32492A (es)
WO (1) WO2010105995A2 (es)
ZA (1) ZA201106668B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS58011B1 (sr) 2010-03-16 2019-02-28 Titan Pharmaceuticals Inc Heterogena implantabilna sredstva za isporuku lekova
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US10406336B2 (en) 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
EP3784247A1 (en) * 2018-04-27 2021-03-03 Evestra, Inc. Estrogen prodrugs and methods of administering estrogen prodrugs
CN112137975A (zh) * 2020-10-30 2020-12-29 厦门汇承药业有限公司 一种烯丙孕素片及其干法制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417182A (en) 1963-03-25 1968-12-17 Upjohn Co Compositions and treatments using 6-methyl - 16 - methylene - 17alpha - hydroxy-4,6-pregnadiene-3,20-dione 17-acetate
US4472394A (en) 1983-09-19 1984-09-18 G. D. Searle & Co. Method for increasing weight in domestic animals
AU573783B2 (en) * 1984-01-31 1988-06-23 International Foundation For Biochemical Endocrinology Method for promoting growth and improved meat quality with female steroidal hormones
HU203667B (en) 1986-12-11 1991-09-30 Roussel Uclaf Process for producing synergetic zootechnical compositions containing three components
US5147869A (en) 1986-12-11 1992-09-15 Roussel Uclaf Zootechnical compositions
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US7001609B1 (en) * 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
AU2005224056B2 (en) 2004-03-24 2010-03-18 Merck Sharp & Dohme B.V. Drug delivery system based on polyethylene vinylacetate copolymers
JP2010509964A (ja) 2006-11-20 2010-04-02 ナームローゼ・フエンノートチヤツプ・オルガノン らせん形薬物送達システム
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system

Also Published As

Publication number Publication date
UY32492A (es) 2010-10-29
AU2010224957A1 (en) 2011-09-29
CA2755828A1 (en) 2010-09-23
AU2010224957B2 (en) 2016-07-21
US9198857B2 (en) 2015-12-01
WO2010105995A2 (en) 2010-09-23
US20120058171A1 (en) 2012-03-08
ZA201106668B (en) 2014-03-26
WO2010105995A3 (en) 2011-01-20
EP2408423A2 (en) 2012-01-25
US20160038430A1 (en) 2016-02-11
AR076123A1 (es) 2011-05-18
BRPI1009586A2 (pt) 2016-03-08

Similar Documents

Publication Publication Date Title
MX2011009679A (es) Dispositivo de suministro de farmaco zootecnico.
PL2079446T3 (pl) Preparat paliperidonu o przedłużonym uwalnianiu
EP4233978A3 (en) Oral delivery of active drug substances
IL216468A0 (en) Compositions, methods & systems for respiratory respiratory delivery of two or more active agents
IN2012DN01216A (es)
MX2011007930A (es) Conjugados de insulina cristalina.
WO2010096733A3 (en) Luminescent porous silicon nanoparticles, methods of making and using same
MX2010009043A (es) Composicion farmaceutica para farmacos poco solubles.
IN2012DN00829A (es)
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
MX359288B (es) Forma iv del clorhidrato de ivabradina.
WO2010120389A3 (en) Polymeric drug delivery systems and processes for producing such systems
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
GB0907019D0 (en) Pharmaceutical,therapeutic or nutritional delivery systems for functional ingredients
MX353623B (es) Sistema de suministro de farmaco.
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
IN2012DN02793A (es)
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
EA026830B9 (ru) Осмотически активная система вагинальной доставки
MX2010008852A (es) Formulaciones de flibanserina.
WO2010120817A3 (en) Nanochanneled device and related methods
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
GB201007237D0 (en) A holder and a method of using the holder

Legal Events

Date Code Title Description
FG Grant or registration